Advertisement

GH/IGF-I Axis in Exercise

  • Enrico Gabellieri
  • Ignacio Bernabeu
  • Eva Fernandez
  • Monica Marazuela
  • Luca Chiovato
  • Felipe F. Casanueva
Chapter
Part of the Endocrine Updates book series (ENDO, volume 29)

Abstract

Growth hormone (GH) is an important metabolic hormone secreted in a pulsatile manner by the somatotrope cells of the anterior pituitary. Physical exercise is a potent stimulus to GH release. The relevance in exercise performance of GH-IGF-I axis is probably mainly due to its metabolic effects. GH, directly and via insulin-growth-factor I (IGF-I), increases protein synthesis and decreases protein catabolism by mobilizing fat as a principal fuel source during exercise. Several evidences support an important role of an intact GH-IGF-I axis in maintaining normal exercise capacity through a regulation of free fatty acids (FFAs) availability. Positive and significant effects of GH replacement therapy on exercise capacity have been described in growth hormone deficient (GHD) patients. Furthermore, some data show that GH treatment can improve exercise performance in elderly subjects. However, supraphysiological GH plasma levels in normal subject and athletes seems to be ineffective at improving exercise performance or endurance, and the chronic GH excess in acromegalic patients is characterized by impairments in strength and exercise performance. Therefore it is very important, when considering a possible GH treatment, to balance the effectiveness and the safety of this therapy.

Keywords

Growth Hormone Exercise Performance Growth Hormone Secretion Growth Hormone Level Growth Hormone Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev. 1998; 19: 717–797.CrossRefPubMedGoogle Scholar
  2. 2.
    Veldhuis JD. A tripeptidyl ensemble perspective of interactive control of growth hormone secretion. Horm Res. 2003; 60 (Suppl 1): 86–101.CrossRefPubMedGoogle Scholar
  3. 3.
    Sutton J, Lazarus L. Growth hormone in exercise: comparison of physiological and pharmacological stimuli. J Appl Physiol. 1976; 41: 523–527.PubMedGoogle Scholar
  4. 4.
    Christensen SE, Jørgensen OL, Møller N, Orskov H. Characterization of growth hormone release in response to external heating. Comparison to exercise induced release. Acta Endocrinol (Copenh). 1984; 107: 295–301.Google Scholar
  5. 5.
    Felsing NE, Brasel JA, Cooper DM. Effect of low and high intensity exercise on circulating growth hormone in men. J Clin Endocrinol Metab. 1992; 75: 157–162.CrossRefPubMedGoogle Scholar
  6. 6.
    Elias AN, Wilson AF, Naqvi S, Pandian MR. Effects of blood pH and blood lactate on growth hormone, prolactin, and gonadotropin release after acute exercise in male volunteers. Proc Soc Exp Biol Med. 1997; 214: 156–160.PubMedGoogle Scholar
  7. 7.
    Wheldon A, Savine RL, Sönksen PH, Holt RI. Exercising in the cold inhibits growth hormone secretion by reducing the rise in core body temperature. Growth Horm IGF Res. 2006; 16: 125–131.CrossRefPubMedGoogle Scholar
  8. 8.
    Nass R, Huber RM, Klauss V, Müller OA, Schopohl J, Strasburger CJ. Effect of growth ­hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metab. 1995; 80: 552–557.CrossRefPubMedGoogle Scholar
  9. 9.
    Whitehead HM, Boreman C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf). 1992; 36: 45–52.CrossRefGoogle Scholar
  10. 10.
    Beshyah SA, Freemantle C, Shahi M, Anyaoku V, Merson S, Lynch S, Skinner E, Sharp P, Foale R, Johnston DG. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf). 1995; 42: 73–84.CrossRefGoogle Scholar
  11. 11.
    Degerblad M, Almkvist O, Grunditz R, Hall K, Kaijser L, Knutsson E, Ringertz H, Thorén M. Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol (Copenh). 1990; 123: 185–193.Google Scholar
  12. 12.
    Widdowson WM, Gibney J. The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a metaanalysis. J Clin Endocrinol Metab. 2008; 93: 4413–4417.CrossRefPubMedGoogle Scholar
  13. 13.
    Golde DW, Bersch N, Li CH. Growth hormone: species-specific stimulation of erythropoiesis in vitro. Science. 1977; 196: 1112–1113.CrossRefPubMedGoogle Scholar
  14. 14.
    Saccà L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev. 1994; 15: 555–573.PubMedGoogle Scholar
  15. 15.
    Johannsson G, Sverrisdóttir YB, Ellegård L, Lundberg PA, Herlitz H. GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis. J Clin Endocrinol Metab. 2002; 87: 1743–1749.CrossRefPubMedGoogle Scholar
  16. 16.
    Janssen YJ, Doornbos J, Roelfsema F. Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency. J Clin Endocrinol Metab. 1999; 84: 279–284.CrossRefPubMedGoogle Scholar
  17. 17.
    Hunter WM, Fonseka CC, Passmore R. The role of growth hormone in the mobilization of fuel for muscular exercise. Q J Exp Physiol Cogn Med Sci. 1965; 50: 406–416.PubMedGoogle Scholar
  18. 18.
    Wee J, Charlton C, Simpson H, Jackson NC, Shojaee-Moradie F, Stolinski M, Pentecost C, Umpleby AM. GH secretion in acute exercise may result in post-exercise lipolysis. Growth Horm IGF Res. 2005; 15: 397–404.CrossRefPubMedGoogle Scholar
  19. 19.
    Lassarre C, Girard F, Durand J, Raynaud J. Kinetics of human growth hormone during ­submaximal exercise. J Appl Physiol. 1974; 37: 826–830.PubMedGoogle Scholar
  20. 20.
    Pritzlaff-Roy CJ, Widemen L, Weltman JY, Abbott R, Gutgesell M, Hartman ML, Veldhuis JD, Weltman A. Gender governs the relationship between exercise intensity and growth ­hormone release in young adults. J Appl Physiol. 2002; 92: 2053–2060.PubMedGoogle Scholar
  21. 21.
    Wideman L, Consitt L, Patrie J, Swearingin B, Bloomer R, Davis P, Weltman A. The impact of sex and exercise duration on growth hormone secretion. J Appl Physiol. 2006; 101: 1641–1647.CrossRefPubMedGoogle Scholar
  22. 22.
    Kanaley JA, Weltman JY, Veldhuis JD, Rogol AD, Hartman ML, Weltman A. Human growth hormone response to repeated bouts of aerobic exercise. J Appl Physiol. 1997; 83: 1756–1761.PubMedGoogle Scholar
  23. 23.
    Kanaley JA, Weltman JY, Pieper KS, Weltman A, Hartman ML. Cortisol and growth hormone responses to exercise at different times of day. J Clin Endocrinol Metab. 2001; 86: 2881–2889.CrossRefPubMedGoogle Scholar
  24. 24.
    Gilbert KL, Stokes KA, Hall GM, Thompson D. Growth hormone responses to 3 different exercise bouts in 18- to 25- and 40- to 50-year-old men. Appl Physiol Nutr Metab. 2008; 33: 706–712.CrossRefPubMedGoogle Scholar
  25. 25.
    Wideman L, Weltman JY, Shah N, Story S, Veldhuis JD, Weltman A. Effects of gender on exercise-induced growth hormone release. J Appl Physiol. 1999; 87: 1154–1162.PubMedGoogle Scholar
  26. 26.
    Zaccaria M, Varnier M, Piazza P, Noventa D, Ermolao A. Blunted growth hormone response to maximal exercise in middle aged versus young subjects and no effect of endurance training. J Clin Endocrinol Metab. 1999; 84: 2303–2307.CrossRefPubMedGoogle Scholar
  27. 27.
    Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, Pincus S. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab. 1995; 80: 3209–3222.CrossRefPubMedGoogle Scholar
  28. 28.
    Prange Hansen A. Serum growth hormone response to exercise in non-obese and obese normal subjects. Scand J Clin Lab Invest. 1973; 31: 175–178.CrossRefPubMedGoogle Scholar
  29. 29.
    Scacchi M, Valassi E, Ascoli P, Cavagnini F. Obesity, hyponutrition and growth hormone. Obes Metab. 2007; 3: 68–87.Google Scholar
  30. 30.
    Holt RI, Webb E, Pentecost C, Sönksen PH. Aging and physical fitness are more important than obesity in determining exercise- induced generation of GH. J Clin Endocrinol Metab. 2001; 86: 5715–5720.CrossRefPubMedGoogle Scholar
  31. 31.
    Bang P, Brandt J, Degerblad M, Enberg G, Kaijser L, Thorén M, Hall K. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency. Eur J Clin Invest. 1990; 20: 285–292.CrossRefPubMedGoogle Scholar
  32. 32.
    Schwarz AJ, Brasel JA, Hintz RL, Mohan S, Cooper DM. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab. 1996; 81: 3492–3497.CrossRefPubMedGoogle Scholar
  33. 33.
    Wallace JD, Cuneo RC, Baxter R, Orskov H, Keay N, Pentecost C, Dall R, Rosén T, Jørgensen JO, Cittadini A, Longobardi S, Sacca L, Christiansen JS, Bengtsson BA, Sönksen PH. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J Clin Endocrinol Metab. 1999; 84: 3591–3601.CrossRefPubMedGoogle Scholar
  34. 34.
    Healy ML, Gibney J, Pentecost C, Croos P, Russell-Jones DL, Sönksen PH, Umpleby AM. Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletes. J Clin Endocrinol Metab. 2006; 91: 320–327.CrossRefPubMedGoogle Scholar
  35. 35.
    Berggren A, Ehrnborg C, Rosén T, Ellegård L, Bengtsson BA, Caidahl K. Short-term ­administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axes. J Clin Endocrinol Metab. 2005; 90: 3268–3273.CrossRefPubMedGoogle Scholar
  36. 36.
    Nagulesparen M, Trickey R, Davies MJ, Jenkins JS. Muscle changes in acromegaly. Br Med J. 1976; 16: 914–915.CrossRefGoogle Scholar
  37. 37.
    Gibney J, Healy ML, Sönksen PH. The growth hormone/insulin-like growth factor-I axis in exercise and sport. Endocr Rev. 2007; 28: 603–624.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Enrico Gabellieri
    • 1
  • Ignacio Bernabeu
  • Eva Fernandez
  • Monica Marazuela
  • Luca Chiovato
  • Felipe F. Casanueva
  1. 1.Fondazione Salvatore Maugeri Istituto di Ricovero e Cura a Carattere Scientifico, Chair of EndocrinologyUniversity of PaviaPaviaItaly

Personalised recommendations